Feasibility and Reproducibility of HIV-1 Genotype Resistance Test in Very-Low-Level Viremia
暂无分享,去创建一个
L. Sticchi | G. Icardi | A. di Biagio | M. Setti | F. Saladini | B. Bruzzone | R. Barresi
[1] P. Harrigan,et al. Performance of HIV-1 drug resistance testing at low-level viremia and its ability to predict future virologic outcomes and viral evolution in treatment-naive individuals. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[2] P. Harrigan,et al. Significance and Clinical Management of Persistent Low-Level Viremia and Very-Low-Level Viremia in HIV-1-Infected Patients , 2014, Antimicrobial Agents and Chemotherapy.
[3] F. Ceccherini‐Silberstein,et al. Reliability and clinical relevance of the HIV-1 drug resistance test in patients with low viremia levels. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[4] R. Shafer,et al. Update of the drug resistance mutations in HIV-1: March 2013. , 2013, Topics in antiviral medicine.
[5] D. Richman,et al. Update of the drug resistance mutations in HIV-1: December 2010. , 2010, Topics in HIV medicine : a publication of the International AIDS Society, USA.
[6] D. Richman,et al. 2022 update of the drug resistance mutations in HIV-1. , 2022, Topics in antiviral medicine.
[7] V. Soriano,et al. European guidelines for the clinical management and treatment of HIV-infected adults in Europe. , 2003, AIDS.
[8] J. J. Henning,et al. Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents, January 28, 2000 , 1998, HIV clinical trials.